Internal Medicine, Hematology & Oncology · Madison, WI
NPI
1679816805
Since 2013
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
600 Highland Ave
Madison, WI, 53792
Phone (608) 265-1700
Groups this clinician bills Medicare through
Medicare paid, 2024
$42K
859 services
Medicare patients, 2024
131
Average age 73
Drug cost, 2024
$3.4M
1,014 prescriptions
Company payments, 2025
$44.13
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Zhubin J Gahvari was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 272 times for 89 patients. In total Zhubin J Gahvari billed 859 services in 27 codes, and Medicare paid $42K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-01-07.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 272 | 89 | $11.68 | $3,176 |
| 99214 Office E&M - Established | Facility | 171 | 47 | $68.06 | $12K |
| 99233 Hospital E&M - Subsequent | Facility | 119 | 27 | $87.67 | $10K |
| 99215 Office E&M - Established | Facility | 59 | 32 | $104.71 | $6,178 |
| 99213 Office E&M - Established | Facility | 55 | 45 | $43.71 | $2,404 |
| 36415 Venipuncture Blood Collection | Office | 46 | 18 | $8.65 | $398 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 18 | 12 | $9.45 | $170 |
| 99204 Office E&M - New | Facility | 15 | 15 | $98.15 | $1,472 |
| 99238 Hospital Discharge Management | Facility | 14 | 13 | $60.07 | $841 |
| 99205 Office E&M - New | Facility | 11 | 11 | $117.69 | $1,295 |
By year: 2022 $35K for 495 services; 2023 $42K for 631 services; 2024 $42K for 859 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 46 | 18 | $8.65 | $398 |
Medicare prescription drug claims, 2024
In 2024, the drug Zhubin J Gahvari prescribed most often to Medicare patients was Acyclovir, with 161 prescriptions and refills. In total Zhubin J Gahvari wrote 1,014 Medicare prescriptions that cost $3.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Acyclovir Generic | 161 | 276 | 44 | $2,918 |
| Revlimid Lenalidomide | 114 | 114 | 21 | $2.1M |
| Dexamethasone Generic | 87 | 94 | 35 | $1,040 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 53 | 58 | 13 | $263 |
| Prochlorperazine Maleate Generic | 34 | 34 | 25 | $409 |
| Lenalidomide Generic | 34 | 34 | Under 11 | $395K |
| Potassium Chloride Generic | 34 | 60 | Under 11 | $642 |
| Ondansetron Hcl Generic | 33 | 33 | 25 | $200 |
| Zarxio Filgrastim-Sndz | 21 | 21 | Under 11 | $57K |
| Famotidine Generic | 21 | 33 | Under 11 | $320 |
| Gabapentin Generic | 21 | 29 | Under 11 | $271 |
| Valacyclovir Valacyclovir Hcl | 20 | 33 | Under 11 | $1,016 |
| Levofloxacin Generic | 18 | 18 | 12 | $190 |
| Jakafi Ruxolitinib Phosphate | 16 | 16 | Under 11 | $261K |
| Oxycodone Hcl Generic | 15 | 15 | Under 11 | $115 |
Brand drugs: 266 claims; generic drugs: 748 claims; opioid claims: 25.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Zhubin J Gahvari $44.13 ($44.13 in general payments such as food, travel and fees) from 5 companies. The largest payer was Legend Biotech USA Inc. with $25.16.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.